Seer will host a conference call to discuss the fourth quarter and full year 2024 financial results on Thursday, February 27, 2025 at 1:30 pm Pacific Time / 4:30 pm Eastern Time. A webcast of the ...

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of ...

PCI Biotech (OSE: PCIB), today announces its preliminary full year 2024 results. Please find enclosed the interim report and presentation. Highlights review OperationsPCI ...

PCI Biotech's 2024 development goals were to demonstrate scalability and manufacturing process benefits of the ...

Defined culture conditions robustly maintain human stem cell pluripotency, highlighting a role for Ca 2+ signaling Comparative analysis of 100+ PSC lines highlights biological differences ...

PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's full-year 2024 interim report on Thursday 27 ...

This valuable study reports on the critical role of ANKRD5 (ANKEF1) in sperm motility and male fertility. However, the supporting data remain incomplete. This work will be of interest to biomedical ...

Biologists converted gut bacteria into miniature protein factories that manufacture and release a sustained flow of targeted proteins inside the lower intestines. This technique solves one of the ...

Addressing one of the longstanding challenges in gastrointestinal drug delivery, Virginia Tech researchers have transformed ...

It’s hard to say something nice about viruses, but Dr. Joaquín Martínez Martínez can. Dr. Martínez Martínez is a new aquatic virus ecologist at Horn Point who ...

Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...